DFE Pharma has production locations in Europe, India and New Zealand. All locations produce under Pharma cGMP conditions. DFE Pharma continuously invests in cGMP standards and in excipients technologies, having a culture that stimulates the understanding of and cooperation with pharmaceutical customers. We have implemented a single, uniform quality system based on ISO 9001:2015 and IPEC cGMP guidelines in all facilities. Additionally, ICH Q7 is applicable for inhalation grade lactose.